News & Events
Latest NewsView All
AABB22 cancelled due to Hurricane Ian
Devastating category 4 Hurricane Ian has caused the cancellation of 2022 AABB.
The Ukrainian people need the World’s help right now.
The Ukrainian people need the World’s help right now. Haemokinesis has donated 3 pallets of emergency blood grouping consumables.
Haemokinesis turns 10!
Haemokinesis first began on 27 September 2011, now 10 years on, we’re celebrating our achievements.
Haemokinesis Ltd-Swiss branch moves facility.
Haemokinesis Ltd-Swiss branch moves facility from Avenches to Murten in the Canton of Fribourg. The new facility encompasses instrument production, bio production, training, and support facilities. And will act as the European central warehouse for Haemokinesis products.
Philippine Blood Co-ordinating Council Conference 2021
Our channel partner FAS participated in this virtual conference with much positive feedback on Haemokinesis products.
Haemokinesis opens US office
With the approaching launch of GLIF for the pre-donation market, Haemokinesis has established an office and warehouse facility in Steamboat Springs CO.
Dr. Clare Manderson presents paper on Haemokinesis laser incubation technology at the ANZSBT conference in Perth.
Dr. Clare Manderson presents paper on Haemokinesis laser incubation technology at the ANZSBT conference in Perth. Clare wins best presentation at the meeting.
TGA approves STATUS1 and STARGEL10
TGA approves Haemokinesis' STATUS1 and STARGEL10 bench top products including gel cards and reagent red cells.
CE MARK for STATUS1 and STARGEL10
Haemokinesis receives CE certification for STATUS1 and STARGEL10 products.
Launch of DAYmate S product
DAYmate S – the one and only full automate with single well by well processing.
Swiss Facility Acquisition
2018 saw the acquisition of a purpose built immunohaematology facility in Switzerland.
Haemokinesis achieves ISO 13485
ISO 13485 was written to support medical device manufacturers in designing quality management systems.
Haemokinesis in partnership with Monash University receives ARC linkage grant to develop in-vitro diagnostics.
Collaboration between Monash University and Haemokinesis with funding provided through an Australian Research Council (ARC) Linkage granted to develop in-vitro diagnostics.
Media ReleasesView All
|29 March 2021||
International team uncovers mystery behind ‘coffee ring’ formation
|11 Mar 2021||
Post-market evaluation of serology-based point of care COVID-19 tests
|02 Nov 2020||
Radical diagnostic could save millions of people at risk of dying from blood loss
|01 Nov 2020||Download|
|13 May 2020||Download|
|20 Sept 2019||
Blood transfusion breakthrough to save lives
|17 Sept 2019||
SAVING LIVES FASTER: MONASH DEVELOPS WORLD-FIRST LASER INCUBATOR FOR BLOOD
|07 Dec 2015||
Low-cost bioactive paper detects blood types in under a minute.
|07 Dec 2015||Download|
If you have a media enquiry about Haemokinesis, please contact us.
Call +613 9708 6322